Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Privacy



Stock Trading History of Schleifer Leonard S

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Schleifer Leonard S since year 2005. The trader's CIK number is 1218629. At the time of this reporting, Schleifer Leonard S is the Chief Exec Officer & President of Regeneron Pharmaceuticals Inc . (stock ticker symbol REGN). See this page for all insider trading activities at Regeneron Pharmaceuticals Inc .

Stock purchases, sales, and option exercises reported by insider Schleifer Leonard S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2008-09-29 REGN Regeneron Pharmaceuticals Inc Option Exercise 73,010 7.41 541,004
2007-12-20 REGN Regeneron Pharmaceuticals Inc Option Exercise 37,370 8.62 322,316
2006-11-06 REGN Regeneron Pharmaceuticals Inc Option Exercise 150,000 9.06 1,359,375
2006-11-07 REGN Regeneron Pharmaceuticals Inc Sale 53,986 23.12 1,247,920
2006-10-17 REGN Regeneron Pharmaceuticals Inc Sale 30,000 18.02 540,750
2006-09-13 REGN Regeneron Pharmaceuticals Inc Sale 14,100 16.55 233,372
2009-09-13 REGN Regeneron Pharmaceuticals Inc Sale 15,900 16.55 263,176
2006-03-06 REGN Regeneron Pharmaceuticals Inc Sale 700 18.00 12,600
2006-03-07 REGN Regeneron Pharmaceuticals Inc Sale 401 18.00 7,218
2006-03-06 REGN Regeneron Pharmaceuticals Inc Sale 700 18.00 12,600
2006-03-07 REGN Regeneron Pharmaceuticals Inc Sale 401 18.00 7,218
2005-12-27 REGN Regeneron Pharmaceuticals Inc Option Exercise 80,000 12.75 1,020,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schleifer Leonard S (Chief Exec Officer & President of Regeneron Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.